MedPath

Propofol

Generic Name
Propofol
Brand Names
Diprivan
Drug Type
Small Molecule
Chemical Formula
C12H18O
CAS Number
2078-54-8
Unique Ingredient Identifier
YI7VU623SF
Background

Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.

Indication

Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.

Associated Therapies
Induction of anesthesia therapy, Maintenance of anesthesia therapy, Monitored anesthesia care sedation, Sedative therapy

Safety of Driving After Minor Surgery with Monitored Anesthesia Care

Phase 4
Active, not recruiting
Conditions
Minor Surgical Procedures with Monitored Anesthesia Care
Driving Performance After Minor Ambulatory Surgery
Interventions
First Posted Date
2007-12-20
Last Posted Date
2024-12-05
Lead Sponsor
Rush University Medical Center
Target Recruit Count
625
Registration Number
NCT00577200
Locations
🇺🇸

Rush University Medical Center, Chicago, Illinois, United States

Propofol's Hypnotic and Memory Effects

Completed
Conditions
Healthy
Interventions
Drug: Placebo solution
First Posted Date
2007-12-19
Last Posted Date
2016-05-06
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
102
Registration Number
NCT00576615
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Comparison Between Nurse-Administered Propofol Sedation and Diazemuls / Pethidine in Outpatient Colonoscopy

Not Applicable
Completed
Conditions
Colonoscopy
Interventions
First Posted Date
2007-12-03
Last Posted Date
2007-12-03
Lead Sponsor
North District Hospital
Target Recruit Count
194
Registration Number
NCT00566683

Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028)

Phase 3
Completed
Conditions
Anesthesia, General
Interventions
First Posted Date
2007-11-16
Last Posted Date
2019-11-25
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
52
Registration Number
NCT00559468

Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors

Not Applicable
Withdrawn
Conditions
Brain Neoplasms
Interventions
First Posted Date
2007-11-09
Last Posted Date
2017-04-20
Lead Sponsor
The Cleveland Clinic
Registration Number
NCT00555984
Locations
🇺🇸

Cleveland Clinic Foundation, Cleveland, Ohio, United States

Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery

Phase 3
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2007-10-11
Last Posted Date
2015-04-13
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
89
Registration Number
NCT00542542
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

COGNITIVE - Cognitive Function After Sevoflurane or Propofol Anesthesia for Open-heart Operations

Phase 4
Withdrawn
Conditions
Other Functional Disturbances Following Cardiac Surgery
Memory Disorders
Interventions
First Posted Date
2007-10-10
Last Posted Date
2015-10-28
Lead Sponsor
Medical University of Gdansk
Registration Number
NCT00541918
Locations
🇵🇱

Department of Cardiac Anesthesiology, Medical University of Gdańsk, Gdańsk, Poland

🇵🇱

Medical Universty of Gdańsk, Department of Cardiac and Vascular Surgery, Gdańsk, Poland

Opioid-potentiated Volative Anaesthetic Vs. Remifentanil And Propofol During Abdominal Aortic Aneurysm Surgery

Phase 4
Completed
Conditions
Aortic Diseases
Abdominal
Aneurysm
Surgery
Interventions
First Posted Date
2007-10-02
Last Posted Date
2013-03-11
Lead Sponsor
Sykehuset i Vestfold HF
Target Recruit Count
193
Registration Number
NCT00538421
Locations
🇳🇴

Sykehuset i Vestfold HF, Tonsberg, Norway

Precedex Versus Propofol-Awakening for Reducing Brain Injury Expansion

Phase 1
Completed
Conditions
Brain Injury
Intracranial Pressure
Interventions
First Posted Date
2007-10-02
Last Posted Date
2013-04-11
Lead Sponsor
Carmelo Graffagnino
Target Recruit Count
8
Registration Number
NCT00538616
Locations
🇺🇸

Duke University, Durham, North Carolina, United States

Anesthetics and Auditory, Visceral, and Heat Evoked Potentials

Phase 4
Completed
Conditions
Healthy
Interventions
First Posted Date
2007-09-26
Last Posted Date
2007-09-26
Lead Sponsor
Technical University of Munich
Target Recruit Count
60
Registration Number
NCT00534586
Locations
🇩🇪

Technische Universität München, Klinikum rechts der Isar, Department of Anesthesiology, Munich, Bavaria, Germany

© Copyright 2025. All Rights Reserved by MedPath